Preclinical investigations of autocrine CYP24A1 expression in cancer are similar to systemic regulation of vitamin D metabolism in humans, where upregulation of CYP24A1 prevents pathophysiological effects of hypervitaminosis D [16]. The gene discussed is CYP24A1; the disease is cancer.